Clinical Evidence
Two Out of Three: The Evidence Behind Ketamine and Spravato Remission Rates
When a patient has failed two or more antidepressants, the clinical picture shifts. The question is no longer whether their medication needs adjusting — it is whether the standard pharmacological approach is the right tool at all. This is the population ketamine and Spravato were built for. And over the past decade, the evidence has […]